Please find attached herewith unaudited Standalone and Consolidated Financial Results for the quarter and Nine months ended December 31, 2024

Approved Un-Audited Financial Results (Standalone & Consolidated) for the quarter/nine months ended 31.12.2024

Pursuant to Reg 30 and Reg 33 of SEBI (LODR) Reg 2015, the Board of the Directors of the company in its meeting held at 5 Chittaranjan Avenue, Kolkata-700072 on Friday, February 14, 2025 has inter alia approved and taken on record the unaudited financial result for the quarter and nine months ended December 31, 2024. The same is enclosed for your reference alongwith Limited Review report provided by M/s Rakesh Ram & Associates, Statutory Auditors.

Unaudited Financial Results (Standalone) for the Quarter and Nine Months ended 31.12.2024

OUTCOME OF THE MEETING OF THE BOARD OF DIRECTORS OF WELCURE DRUGS AND PHARMACEUTICALS LIMITED HELD ON TODAY 14 FEBRUARY 2025.

As per Attachment

This is to inform you that the Board of Directors of the Company at their meeting held on Friday, February 14, 2025, which commenced at 4:00 PM and concluded at 4.15 PM, has inter-alia considered and approved The Un-audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended December 31, 2024, and Limited Review Report thereon.

Results for the quarter ended 31.12.2024

Enclosed herewith the Outcome of Board meeting along with Unaudited financial results for Quarter and 9 months ended 31st December 2024 followed by the Limited review Report

Declaration of Unaudited financial results for quarter and nine months ended on December 31, 2024.